Corbus Pharmaceuticals Holdings (CRBP) Revenue (2015 - 2021)

Corbus Pharmaceuticals Holdings' Revenue history runs 7 years deep, the most recent figure standing at $97323.0 for Q3 2021.

• In Q3 2021, Revenue fell 92.09% year-over-year to $97323.0; the TTM figure through Jun 2022 stood at $97323.0 (down 97.39% YoY), while the FY2021 annual figure was $881705.0, down 82.37% from the prior year.
• Revenue was $97323.0 for Q3 2021 at Corbus Pharmaceuticals Holdings, down from $136558.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $29.1 million in Q2 2019 to a low of -$28.6 million in Q4 2019.
• Historically, Revenue has averaged $912103.7 across 5 years, with a median of $902044.0 in 2018.
• Biggest YoY gain for Revenue was 3308.27% in 2019; the steepest drop was 14313.95% in 2019.
• A 5-year view of Revenue shows it stood at $796312.0 in 2017, then sank by 74.76% to $201000.0 in 2018, then tumbled by 14313.95% to -$28.6 million in 2019, then jumped by 106.02% to $1.7 million in 2020, then plunged by 94.34% to $97323.0 in 2021.
• The last three Revenue figures came in at $97323.0 (Q3 2021), $136558.0 (Q2 2021), and $647824.0 (Q1 2021), per Business Quant data.